We urgently need a vaccine for COVID-19 but exposing humans to a vaccine candidate that hasn't undergone the usual safety assessments is risky.
It is critical to learn more about SARS-CoV-2, including its source and why transmission appears to be more efficient than with previous coronaviruses.
Scientists are pursuing several different avenues to develop a vaccine for the novel coronavirus, but the process could take years.
Researchers around the world are working together to control the coronavirus outbreak, now known as COVID-19. This is what's behind the global effort to develop a vaccine.
The oral polio vaccine is most commonly used in the developing world, despite one big problem.
CDC/Alan Janssen, MSPH
A challenge in eradicating polio comes from a version of the vaccine itself, which relies on live but attenuated virus. Rationally designing a new vaccine could help get rid of polio once and for all.
A Masai herdsman walks with his cattle in Amboseli National Park in Kenya.
Lung plague attacks cattle causing disease and death, and more than US$60 million in losses annually in Africa. A new vaccine could prevent the disease.
Vaccines need to be kept cold to remain effective. A lack of power in remote areas makes this difficult, reducing the reach of the life-saving pharmaceuticals.
Manufacturing one of the world's most important vaccines will have several benefits for South Africa.
Could the yearly flu shot become a thing of the past?
AP Photo/Darron Cummings, File
Flu virus mutates so quickly that one year's vaccine won't work on the next year's common strains. But rational design – a new way to create vaccines – might pave the way for more lasting solutions.
Current plans to eradicate polio mean keeping the virus alive – and risk restarting the epidemic.
Computers may play an important role in preparing us for the next viral outbreak – whether flu or Ebola.
UW Institute for Protein Design
This antivirus software protects health, not computers. Researchers are beginning to combat deadly infections using computer-generated antiviral proteins – a valuable tool to fight a future pandemic.
What if it wasn’t back to the drawing board every year for a new flu shot?
Flu virus mutates so quickly that one year's vaccine won't work on the next year's common strains. But a new way to create vaccines, called 'rational design,' might pave the way for more lasting solutions.
HIV plays hide and seek with the body’s immune system to evade detection. But we can learn from its tactics to make a range of vaccines against infectious diseases.
Researchers are learning how HIV hides from the immune system to develop a new generation of vaccines for seemingly unrelated diseases, like the flu.
Saving lives one needle at a time.
Big pharma is finally starting to pay attention to the developing world. Here's why.
Researchers are cautiously optimistic about a new treatment for Parkinson’s.
Affiris, a biotech company based in Austria, and the Michael J Fox Foundation, have announced the latest results of a vaccine they have been developing to treat Parkinson’s disease. Following the first…
Fighter in the war against AIDS.
All scientists have that moment when an idea is initiated or when things come together and a project flourishes. One such moment for me came at a Keystone scientific meeting in South Carolina in 1994…
Researchers from Vanderbilt University have discovered a new method of vaccination where tiny gold particles target immune…
Flu jabs made faster. Leave patients happier. Make fighting pandemics easier.
The 2009 influenza pandemic prompted the fastest effort in history to develop a vaccine. Within six months of the pandemic…
The first ever “atlas” of T cells in the human body has been created, providing a unique view of how the cells function in…
Scientists worked with Hendra virus at the highest level of biosafety within CSIRO’s Australian Animal Health Laboratory.
Today we are launching Equivac® HeV, the world’s first commercially available Hendra vaccine for horses. This breakthrough is the culmination of a scientific journey that dates back to the emergence of…
Scanning electron micrograph of HIV-1 budding (in green) from cultured lymphocyte.
CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManus
Despite three decades of research, an HIV vaccine remains elusive. The main reason for this is the virus’s uncanny ability to evolve resistance to immune control, so understanding how the virus adapts…